← NDC auxiliary source history
FDA Establishment Identifier 946499746
Every current compounder row and every parsed outsourcing-response revision row carrying this exact FEI. Repeated physical rows and parser-specific revisions remain visible.
Establishment names in FDA source rows#
| Exact source name |
|---|
| Hikma Pharmaceuticals USA Inc. |
Exact matches in existing FDA.report company datasets#
Company links appear only when an indexed FDA.report dataset contains the exact establishment name.
| Company | Matching dataset |
|---|---|
| Hikma Pharmaceuticals USA Inc. | NDC |
Current compounder rows#
| Current source record | Source row | Product NDC | Package NDC | Active ingredient | Establishment | Period | Source date | Normalization | Row hash |
|---|---|---|---|---|---|---|---|---|---|
outsourcing:2026-1:387 | 387 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2026-1 | 2026-10-17 | valid | 60d281df870e… |
outsourcing:2026-1:388 | 388 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2026-1 | 2026-10-17 | valid | 53e7a1fd1796… |
outsourcing:2026-1:790 | 790 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | 2026-1 | 2026-10-17 | valid | 0f191eeec916… |
outsourcing:2025-2:378 | 378 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-2 | 2026-10-17 | valid | d69e41eb631e… |
outsourcing:2025-2:379 | 379 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-2 | 2026-10-17 | valid | c2db4e493bc3… |
outsourcing:2025-1:382 | 382 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-1 | 2026-10-17 | valid | d92a761c1a8e… |
outsourcing:2025-1:397 | 397 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-1 | 2026-10-17 | valid | dde5e4c6eb04… |
outsourcing:2024-2:437 | 437 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-2 | 2026-10-17 | valid | 289af58e3347… |
outsourcing:2024-2:438 | 438 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-2 | 2026-10-17 | valid | 775983367602… |
outsourcing:2024-1:421 | 421 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-1 | 2026-10-17 | valid | 5ee57b06f685… |
outsourcing:2024-1:422 | 422 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-1 | 2026-10-17 | valid | b48115627271… |
outsourcing:2023-2:449 | 449 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-2 | 2026-10-17 | valid | 2fc492834764… |
outsourcing:2023-2:450 | 450 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-2 | 2026-10-17 | valid | e87739ab2f74… |
outsourcing:2023-1:480 | 480 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-1 | 2026-10-17 | valid | 7f05b1c8749b… |
outsourcing:2023-1:481 | 481 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-1 | 2026-10-17 | valid | cff8c84eef0f… |
outsourcing:2022-2:397 | 397 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-2 | 2026-10-17 | valid | f18993f2f8ab… |
outsourcing:2022-2:398 | 398 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-2 | 2026-10-17 | valid | 3b23e1d6c20b… |
outsourcing:2022-1:473 | 473 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-1 | 2026-10-17 | valid | 1e19543c7acb… |
outsourcing:2022-1:474 | 474 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-1 | 2026-10-17 | valid | b6b99bff61a4… |
Parsed outsourcing-response revision rows#
These are physical source-row memberships from every distinct parsed response revision, not deduplicated current records.
| Parsed revision | Source JSON | Period | Source date | Product NDC | Package NDC | Active ingredient | Establishment | Parser | Row hash |
|---|---|---|---|---|---|---|---|---|---|
26401944f0d9… | 387 | 2026-1 | 2026-10-17 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
26401944f0d9… | 388 | 2026-1 | 2026-10-17 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
26401944f0d9… | 790 | 2026-1 | 2026-10-17 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
99d030b66ced… | 378 | 2025-2 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
99d030b66ced… | 379 | 2025-2 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
70be8564e342… | 382 | 2025-1 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
70be8564e342… | 397 | 2025-1 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
b4ffc30c9e73… | 437 | 2024-2 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
b4ffc30c9e73… | 438 | 2024-2 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
e467e4495aa8… | 421 | 2024-1 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
e467e4495aa8… | 422 | 2024-1 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
79d657206768… | 449 | 2023-2 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
79d657206768… | 450 | 2023-2 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
f8c2f44b68b7… | 480 | 2023-1 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
f8c2f44b68b7… | 481 | 2023-1 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
ca52fdfc2d3c… | 397 | 2022-2 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
ca52fdfc2d3c… | 398 | 2022-2 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
31a3169ca828… | 473 | 2022-1 | 2026-10-17 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
31a3169ca828… | 474 | 2022-1 | 2026-10-17 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
da73455c5d93… | 387 | 2026-1 | 2026-10-15 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
da73455c5d93… | 388 | 2026-1 | 2026-10-15 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
da73455c5d93… | 790 | 2026-1 | 2026-10-15 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
501ab715e818… | 378 | 2025-2 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
501ab715e818… | 379 | 2025-2 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
eca3cf3c921a… | 382 | 2025-1 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
eca3cf3c921a… | 397 | 2025-1 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
0dd577ad734f… | 437 | 2024-2 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
0dd577ad734f… | 438 | 2024-2 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
90078b592e7c… | 421 | 2024-1 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
90078b592e7c… | 422 | 2024-1 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
14092521032b… | 449 | 2023-2 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
14092521032b… | 450 | 2023-2 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
f9f81ea6f489… | 480 | 2023-1 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
f9f81ea6f489… | 481 | 2023-1 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
b376e476a3cb… | 397 | 2022-2 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
b376e476a3cb… | 398 | 2022-2 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
f491946bf5cd… | 473 | 2022-1 | 2026-10-15 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
f491946bf5cd… | 474 | 2022-1 | 2026-10-15 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
8f6618397ccf… | 387 | 2026-1 | 2026-10-13 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
8f6618397ccf… | 388 | 2026-1 | 2026-10-13 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
8f6618397ccf… | 790 | 2026-1 | 2026-10-13 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
0b540c88a281… | 378 | 2025-2 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
0b540c88a281… | 379 | 2025-2 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
e8f0a02c6277… | 382 | 2025-1 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
e8f0a02c6277… | 397 | 2025-1 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
ab5e3ddbdea5… | 437 | 2024-2 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
ab5e3ddbdea5… | 438 | 2024-2 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
48d98472964b… | 421 | 2024-1 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
48d98472964b… | 422 | 2024-1 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
f453c8821360… | 449 | 2023-2 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
f453c8821360… | 450 | 2023-2 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
c0e29d3245bd… | 480 | 2023-1 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
c0e29d3245bd… | 481 | 2023-1 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
43d2db2a537a… | 397 | 2022-2 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
43d2db2a537a… | 398 | 2022-2 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
5511ae910d60… | 473 | 2022-1 | 2026-10-13 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
5511ae910d60… | 474 | 2022-1 | 2026-10-13 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
610bbcb3a755… | 387 | 2026-1 | 2026-10-06 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
610bbcb3a755… | 388 | 2026-1 | 2026-10-06 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
610bbcb3a755… | 790 | 2026-1 | 2026-10-06 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
133d69db39e2… | 378 | 2025-2 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
133d69db39e2… | 379 | 2025-2 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
790c65a73fbe… | 382 | 2025-1 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
790c65a73fbe… | 397 | 2025-1 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
62f3d4e8f094… | 437 | 2024-2 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
62f3d4e8f094… | 438 | 2024-2 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
4d4f32c25241… | 421 | 2024-1 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
4d4f32c25241… | 422 | 2024-1 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
23646ca3c8e3… | 449 | 2023-2 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
23646ca3c8e3… | 450 | 2023-2 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
d92133e068e1… | 480 | 2023-1 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
d92133e068e1… | 481 | 2023-1 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
39402398034a… | 397 | 2022-2 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
39402398034a… | 398 | 2022-2 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
b484d859e7fc… | 473 | 2022-1 | 2026-10-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
b484d859e7fc… | 474 | 2022-1 | 2026-10-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
3122cd800ba0… | 387 | 2026-1 | 2026-10-05 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
3122cd800ba0… | 388 | 2026-1 | 2026-10-05 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
3122cd800ba0… | 790 | 2026-1 | 2026-10-05 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
6dba8ea2e057… | 378 | 2025-2 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
6dba8ea2e057… | 379 | 2025-2 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
afcce5d51043… | 382 | 2025-1 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
afcce5d51043… | 397 | 2025-1 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
e95ec19a3847… | 437 | 2024-2 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
e95ec19a3847… | 438 | 2024-2 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
fcea7e9fa339… | 421 | 2024-1 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
fcea7e9fa339… | 422 | 2024-1 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
b8f483e10326… | 449 | 2023-2 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
b8f483e10326… | 450 | 2023-2 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
76ce6ed091c4… | 480 | 2023-1 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
76ce6ed091c4… | 481 | 2023-1 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
7d50b7334129… | 397 | 2022-2 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
7d50b7334129… | 398 | 2022-2 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
5e63a15a2836… | 473 | 2022-1 | 2026-10-05 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
5e63a15a2836… | 474 | 2022-1 | 2026-10-05 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
3cdff26f25c4… | 387 | 2026-1 | 2026-10-03 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
3cdff26f25c4… | 388 | 2026-1 | 2026-10-03 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
3cdff26f25c4… | 790 | 2026-1 | 2026-10-03 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
f9f132cf2e29… | 378 | 2025-2 | 2026-10-03 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
f9f132cf2e29… | 379 | 2025-2 | 2026-10-03 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |